Lamotrigine Extended Release Tablets

PresolicitationActive

Key Takeaways

  • No response deadline specified - contact the agency for details
  • Full and open competition - all businesses eligible to bid
  • Work to be performed in PHILADELPHIA, PA
  • Industry: Pharmaceutical Preparation Manufacturing

Contract Details

Notice ID
SPE2D220R0059
Opportunity Type
Presolicitation
Sub-Agency
DEFENSE LOGISTICS AGENCY
Office
DLA TROOP SUPPORT
Posted Date
Tuesday, December 31, 2019
Response Deadline
Not specified
PSC Code
6505
Set-Aside
Full & Open Competition
Place of Performance
PHILADELPHIA, PA, 19111
Status
Active

Description

The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Lamotrigine ER. Procurement details follow. Lamotrigine ER 24 in 25MG, 50MG, 100MG, 200MG, 250MG and 300MG Tablets in 30 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual estimated usage es

Why This Opportunity Matters

The Department of DEFENSE is actively seeking qualified contractors for pharmaceutical preparation manufacturing in PHILADELPHIA, PA.